drugset / Trial / NCT02378142
Pazopanib for Treating Uterine Leiomyosarcoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test any good and bad effects of the study drug pazopanib.
Timeline
- Start
- 2015-03
- Primary completion
- 2018-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pazopanib | Small molecule | 800 mg | Oral |